Physician profile
Gerald Shute
NPI 1700847431
$6,968.67
in general payments reported to CMS, 2019-2025
8 companies · $4,965 in 2025
The $4,965 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $872 · 2021: $131 · 2022: $414 · 2023: $468 · 2024: $119 · 2025: $4,965.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,800 · Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,800.00 |
| Food and Beverage | $752.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fuse Medical, INC. | $4,800.00 | 2025 | Sterizo Total Knee System |
| Stryker Corporation | $1,537.06 | 2019-2023 | Insignia, Mako, Ozark Cervical Plate System |
| Smith+Nephew, INC. | $240.71 | 2019-2025 | Journey II, Real Intelligence, Or3o Dual Mobility |
| Orthofix Medical, INC. | $158.22 | 2022-2025 | Physio-Stim, Spinal-Stim |
| Zimmer Biomet Holdings, INC. | $155.30 | 2019-2025 | Mymobility Platform, Gel-One Cross-Linked Hyaluronate |
| Bioventus LLC | $26.69 | 2019-2021 | |
| Mimedx Group, INC. | $25.75 | 2024 | |
| Abbott Laboratories | $24.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Shute listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.